Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M54,578Revenue (TTM) $M11,397Net Margin (%)2.9Altman Z-Score1.2
Enterprise Value $M76,019EPS (TTM) $1.6Operating Margin %8.4Piotroski F-Score5
P/E(ttm)120Beneish M-Score-1.5Pre-tax Margin (%)4.2Higher ROA y-yN
Price/Book1.910-y EBITDA Growth Rate %--Quick Ratio0.5Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %18.7Current Ratio1.0Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %57.1ROA % (ttm)0.7Higher Current Ratio y-yY
Dividend Yield %0.4PEG3.8ROE % (ttm)1.6Less Shares Outstanding y-yN
Payout Ratio %41.0Shares Outstanding M302ROIC % (ttm)3.5Gross Margin Increase y-yN

Gurus Latest Trades with SHPG

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

SHPG is held by these investors:



SHPG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about SHPG:

News about SHPG:

Articles On GuruFocus.com
Keeley All Cap Value Fund Comments on Shire Jan 27 2017 
KEELEY All Cap Value Fund 4th Quarter Commentary Jan 27 2017 
Third Avenue Value Fund Buys 2 Stocks and Adds to 2 Positions in Q4 Dec 23 2016 
Julian Robertson Sells Delta Air Lines, Alphabet Dec 07 2016 
John Paulson's Largest 3rd Quarter Trades Dec 01 2016 
Momenta Pharmaceuticals Announces Positive Results for Humira Biosimilar Nov 30 2016 
Samuel Isaly Makes 9 New Buys in 3rd Quarter Nov 04 2016 
Martin Whitman's Top Recent Investments Oct 12 2016 
John Paulson’s Health Care Picks Plunge in Flat Year for Sector Oct 06 2016 
Whitman's Third Avenue Buys 3 Pharma Stocks in 3rd Quarter Sep 27 2016 

More From Other Websites
SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits Feb 21 2017
Shire Plc :SHPG-US: Earnings Analysis: Q4, 2016 By the Numbers : February 21, 2017 Feb 21 2017
Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View Feb 17 2017
Shire PLC 4Q Earnings, Revenue Beat Street Feb 17 2017
SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits Feb 17 2017
Drugmaker Shire Tops Q4 Views; Stock Pops To Six-Week High Feb 16 2017
Is this the FTSE 100’s top growth stock? Feb 16 2017
Shire beats Street 4Q forecasts Feb 16 2017
Shire beats Street 4Q forecasts Feb 16 2017
Shire Reports Full Year 2016 Results With Record Revenue; Positioned for Continued Strong Growth... Feb 16 2017
Shire Beats Full-Year Earnings Estimates, Sees Robust 2017 Growth Feb 16 2017
SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits Feb 15 2017
Amicus Therapeutics Updates Migalastat Drug Feb 15 2017
Shire to Highlight Advancements in Rare Genetic Diseases Feb 14 2017
Shire ViroPharma Sued By FTC Over Sham FDA Filings Feb 08 2017
FTC says Shire unit used illegal tactics to block generic competition Feb 07 2017
Shire Responds to U.S. Federal Trade Commission Civil Action Feb 07 2017
Hemophilia Drug Market Competitive Ramps Up Feb 07 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)